Results 251 to 260 of about 3,734,628 (292)

Three novel Enterobacter cloacae bacteriophages for therapeutic use from Ghanaian natural waters. [PDF]

open access: yesArch Virol
Lyytinen OL   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Therapeutic Use of Nicergoline

Clinical Drug Investigation, 2008
The ergot alkaloid derivative nicergoline became clinically available about 35 years ago in the 1970s. Nicergoline has a broad spectrum of action: (i) as an alpha(1)-adrenoceptor antagonist, it induces vasodilation and increases arterial blood flow; (ii) it enhances cholinergic and catecholaminergic neurotransmitter function; (iii) it inhibits platelet
Bengt Winblad   +6 more
openaire   +3 more sources

Therapeutic Use Exemptions

2017
The introduction, in 2004, of the World Anti-Doping Code and a standardized "prohibited list" of substances and methods proscribed in sport represented a consistent, international response to the escalating challenge of drug misuse in contemporary sport.
David, Gerrard, Andrew, Pipe
openaire   +2 more sources

Therapeutic Use of Albumin

Survey of Anesthesiology, 1980
Increasing use of normal human serum albumin may be contributing to the rising cost of medical care. To investigate whether albumin is extensively overused or abused, a study of the quality of albumin use was conducted in a Veterans Administration Hospital.
M R, Alexander   +3 more
openaire   +2 more sources

Therapeutic Use of Calcitriol

Current Vascular Pharmacology, 2014
The synthesis of 1α,25-dihydroxyvitamin D3 (Calcitriol) takes place mostly in the kidneys through the action of 1α-hydroxylase (CYP27B1) which converts 25(OH)D into 1,25(OH)2D3. Renal production of calcitriol is stimulated by PTH, low calcium and low phosphate and it is reduced by high phosphate and FGF23.
Mariano, Rodriguez   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy